Literature DB >> 26989205

The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

Emanuele Zucca1, Francesco Bertoni2.   

Abstract

Extranodal marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) arise from lymphoid populations that are induced by chronic inflammation in extranodal sites. The best evidence of an etiopathogenetic link is provided by the association between Helicobacter pylori-positive gastritis and gastric MALT lymphoma. Indeed, successful eradication of this microorganism with antibiotics can be followed by gastric MALT lymphoma regression in most cases. Other microbial agents have been implicated in the pathogenesis of MZ lymphoma arising at different sites. Apart from gastric MALT lymphoma, antibiotic therapies have been adequately tested only in ocular adnexal MALT lymphomas where upfront doxycycline may be a reasonable and effective initial treatment of patients with Chlamydophila psittaci-positive lymphoma before considering more aggressive strategies. In all other instances, antibiotic treatment of nongastric lymphomas remains investigational. Indeed, there is no clear consensus for the treatment of patients with gastric MALT lymphoma requiring further treatment beyond H pylori eradication or with extensive disease. Both radiotherapy and systemic treatments with chemotherapy and anti-CD20 antibodies are efficacious and thus the experience of individual centers and each patient's preferences in terms of adverse effects are important parameters in the decision process.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26989205     DOI: 10.1182/blood-2015-12-624304

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.

Authors:  Luciano Cascione; Andrea Rinaldi; Alessio Bruscaggin; Chiara Tarantelli; Alberto J Arribas; Ivo Kwee; Lorenza Pecciarini; Afua A Mensah; Valeria Spina; Elaine Y L Chung; Lodovico Terzi di Bergamo; Stephan Dirnhofer; Alexandar Tzankov; Roberto N Miranda; Ken H Young; Alexandra Traverse-Glehen; Gianluca Gaidano; Steven H Swerdlow; Randy Gascoyne; Raul Rabadan; Maurilio Ponzoni; Govind Bhagat; Davide Rossi; Emanuele Zucca; Francesco Bertoni
Journal:  Haematologica       Date:  2019-04-24       Impact factor: 9.941

2.  G-protein coupled receptor (GPCR) mutations in lymphoid malignancies: linking immune signaling activation and genetic abnormalities.

Authors:  Jose Angel Martinez-Climent
Journal:  Haematologica       Date:  2018-08       Impact factor: 9.941

3.  A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue.

Authors:  Hui-Jen Tsai; John Jen Tai; Li-Tzong Chen; Ming-Shiang Wu; Kun-Huei Yeh; Chung-Wu Lin; Tsang-En Wang; Hsiu-Po Wang; Fang-Jung Yu; Jyh-Ming Liou; Chin-Fu Hsiao; Tsu-Yao Cheng; Hong-Jen Yeh; Chung-Wang Ko; Ming-Jen Chen; Gin-Ho Lo; Ping-I Hsu; Cheng-Shyong Chang; Wei-Shou Hwang; Shih-Sung Chuang; Hsiao-Wei Lee; Chia-Tung Shun; Chang-Fang Chiu; Wen-Ming Wang; Ching-Yun Hsieh; Tsang-Wu Liu; Jaw-Town Lin; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  Haematologica       Date:  2019-11-14       Impact factor: 9.941

4.  Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment.

Authors:  Annarita Conconi; Catherine Thieblemont; Luciano Cascione; Valter Torri; Barbara Kiesewetter; Gloria Margiotta Casaluci; Gianluca Gaidano; Markus Raderer; Franco Cavalli; Armando Lopez Guillermo; Peter W Johnson; Emanuele Zucca
Journal:  Haematologica       Date:  2020-01-02       Impact factor: 9.941

Review 5.  Marginal Zone Lymphoma: State-of-the-Art Treatment.

Authors:  Ariel Sindel; Taha Al-Juhaishi; Victor Yazbeck
Journal:  Curr Treat Options Oncol       Date:  2019-12-05

6.  Synchronous MALT lymphoma of the colon and stomach and regression after eradication of Strongyloides stercoralis and Helicobacter pylori.

Authors:  Kevin Singh; Soren Gandhi; Behzad Doratotaj
Journal:  BMJ Case Rep       Date:  2018-07-03

Review 7.  How do we sequence therapy for marginal zone lymphomas?

Authors:  Alessandro Broccoli; Pier Luigi Zinzani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

8.  Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.

Authors:  Adrien Bosseboeuf; Delphine Feron; Anne Tallet; Cédric Rossi; Cathy Charlier; Laurent Garderet; Denis Caillot; Philippe Moreau; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap; Alfreda Destea Nelson; Bridget S Wilson; Hélène Perreault; Eric Piver; Pierre Weigel; François Girodon; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  JCI Insight       Date:  2017-10-05

9.  The use of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography integrated with computed tomography for accurate staging and surveillance in the case of mucosa-associated lymphoid tissue.

Authors:  Shunqing Zhang; Allen Rossetti-Chung; Sumit Sood; Stephanie Terezakis
Journal:  J Radiol Case Rep       Date:  2021-03-31

10.  Diagnosis of MALT Lymphoma from Surveillance Endoscopy of a Patient with a CDH1 Gene Germline Mutation.

Authors:  Cláudia Pinto; Ana Luísa Cunha; Ângelo Rodrigues; Renata Dias; Catarina Brandão; Mário Dinis-Ribeiro
Journal:  GE Port J Gastroenterol       Date:  2021-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.